NCT00190268 Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00185211 BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study Status COMPLETED Phase PHASE3
NCT00179478 Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00176592 Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI Status COMPLETED Phase PHASE4
NCT00156676 Restoration of Walking in Multiple Sclerosis Using Treadmill Training. Status COMPLETED Phase NA
NCT00151801 Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients Status UNKNOWN Phase PHASE2
NCT00151294 The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis Status TERMINATED Phase PHASE4
NCT00146068 EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00139789 A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00137176 EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis Status COMPLETED Phase NA
NCT00134563 Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3